Buys
Open market- Shares
- Avg price
- Total value
Martin Louis Wilson - General Counsel at ROCKET PHARMACEUTICALS, INC.
Issuer-level insider activity
- Role
- General Counsel
- Issuer ticker
- RCKT, RCKTW on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Martin Louis Wilson in ROCKET PHARMACEUTICALS, INC.
Sells
Open market- Shares
- -32,999
- Avg price
- $3.20
- Total value
- -$105,596
Net
Past year- Shares
- -32,999
- Share %
- -100%
- Total value
- -$105,596
Reported holdings for Martin Louis Wilson in ROCKET PHARMACEUTICALS, INC.
Form 4 holding
General Counsel
ROCKET PHARMACEUTICALS, INC.
- Security class
- Common Stock
- Shares / value
- 677,977
- Estimated value
- $2,043,422
- Report date
- 19 May 2026
- Price
- $3.01
- Ownership
- Direct
Form 4 holding
General Counsel
ROCKET PHARMACEUTICALS, INC.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 468,187
- Estimated value
- $2,025,016
- Report date
- 11 Feb 2026
- Price
- $15.04
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Martin Louis Wilson in ROCKET PHARMACEUTICALS, INC.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.